BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Johnston MP, Khakoo SI. Immunotherapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2019; 25(24): 2977-2989 [PMID: 31293335 DOI: 10.3748/wjg.v25.i24.2977]
URL: https://www.wjgnet.com/2218-6190/full/v25/i24/2977.htm
Number Citing Articles
1
Farzam Vaziri, Steven D. Colquhoun, Yu-Jui Yvonne Wan. Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiomeLiver Research 2020; 4(4): 191 doi: 10.1016/j.livres.2020.10.001
2
Thuzar Hla Shwe, Peraphan Pothacharoen, Thanyaluck Phitak, Benjawan Wudtiwai, Prachya Kongtawelert. Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma CellsInternational Journal of Molecular Sciences 2021; 22(16): 8755 doi: 10.3390/ijms22168755
3
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar. Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitorsMeditsinskiy sovet = Medical Council 2021; (20): 84 doi: 10.21518/2079-701X-2021-20-84-93
4
Dafeng Xu, Yu Wang, Jincai Wu, Shixun Lin, Yonghai Chen, Jinfang Zheng. Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinomaCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02326-8
5
Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser. CD73's Potential as an Immunotherapy Target in Gastrointestinal CancersFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00508
6
Erin Bresnahan, Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio. Mouse Models of Oncoimmunology in Hepatocellular CarcinomaClinical Cancer Research 2020; 26(20): 5276 doi: 10.1158/1078-0432.CCR-19-2923
7
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in CancersPhysiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
8
Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, Giovanni Brandi. First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesExpert Review of Gastroenterology & Hepatology 2021; 15(11): 1245 doi: 10.1080/17474124.2021.1973431
9
Vibha Sinha, Sapnita Shinde, Vinit Singh Baghel, Naveen Kumar Vishvakarma, Dhananjay Shukla, Atul Kumar Tiwari, Ashwini Kumar Dixit, Sanjay Kumar Pandey, Sudhakar Dwivedi, Mrinalini Singh, Vineeta Dixit. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 43 doi: 10.1016/B978-0-323-99283-1.00018-5
10
Ievgen V. Pylypchuk, Huizhen Suo, Chanakarn Chucheepchuenkamol, Nils Jedicke, Pär A. Lindén, Mikael E. Lindström, Michael P. Manns, Olena Sevastyanova, Tetyana Yevsa. High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver CancerFrontiers in Bioengineering and Biotechnology 2022; 9 doi: 10.3389/fbioe.2021.817768
11
Dhatri Madduru, Ngalah Bidii Stephen, Urvashi Vijay, Pranathi Pappu, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 225 doi: 10.1016/B978-0-323-99283-1.00021-5
12
Igor V. Komarov, Ganna Tolstanova, Halyna Kuznietsova, Natalia Dziubenko, Petro I. Yanchuk, Lydia Y. Shtanova, Stanislav P. Veselsky, Liudmyla V. Garmanchuk, Nataliia Khranovska, Oleksandr Gorbach, Taisa Dovbynchuk, Petro Borysko, Oleg Babii, Tim Schober, Anne S. Ulrich, Sergii Afonin. Towards in vivo photomediated delivery of anticancer peptides: Insights from pharmacokinetic and -dynamic dataJournal of Photochemistry and Photobiology B: Biology 2022; 233: 112479 doi: 10.1016/j.jphotobiol.2022.112479
13
Xinhui Shi, Qisong Li, Yungang Wang. Impact of regulatory T cells on the prognosis of hepatocellular carcinomaMedicine 2021; 100(3): e23957 doi: 10.1097/MD.0000000000023957
14
Zakaria Mohamed Alghzzawy, Tarek Khaled Elmaghraby, Sanaa Abd El-Hamid Hagag, Mohammed Hussein Awwad. Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expressionMolecular Biology Reports 2020; 47(3): 1883 doi: 10.1007/s11033-020-05282-0
15
Kumar Jayant, Nagy Habib, Kai W. Huang, Mauro Podda, Jane Warwick, Ramesh Arasaradnam. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through ImmunomodulationVaccines 2020; 8(2): 247 doi: 10.3390/vaccines8020247
16
Isabella Lurje, Linda Hammerich, Frank Tacke. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver CancerInternational Journal of Molecular Sciences 2020; 21(19): 7378 doi: 10.3390/ijms21197378
17
Jiejun Hu, Dong Cai, Zhibo Zhao, Guo-Chao Zhong, Jianping Gong. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling PathwayFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659676
18
Qingzhu Jia, Han Chu, Zheng Jin, Haixia Long, Bo Zhu. High-throughput single-сell sequencing in cancer researchSignal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-00990-4
19
Xi Li, S. Ali Montazeri, Ricardo Paz-Fumagalli, Carlos A. Padula, Weiping Wang, Kabir Mody, Lewis R. Roberts, Tushar Patel, Sunil Krishnan, Beau Toskich. Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass MicrospheresEuropean Journal of Nuclear Medicine and Molecular Imaging 2021; 48(8): 2624 doi: 10.1007/s00259-020-05186-y
20
Fei Lu, Xiao-Jing-Nan Ma, Wei-Lin Jin, Yang Luo, Xun Li. Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and ChallengesFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.690565
21
Mark Farha, Neil K. Jairath, Theodore S. Lawrence, Issam El Naqa. Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular CarcinomaJCO Clinical Cancer Informatics 2020; (4): 1002 doi: 10.1200/CCI.20.00077
22
Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo. Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resectionPersonalized Medicine 2020; 17(2): 83 doi: 10.2217/pme-2018-0114
23
Yetirajam Rajesh, Devanand Sarkar. Molecular Mechanisms Regulating Obesity-Associated Hepatocellular CarcinomaCancers 2020; 12(5): 1290 doi: 10.3390/cancers12051290
24
Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Ferdinando Carlo Sasso. HCC and Molecular Targeting Therapies: Back to the FutureBiomedicines 2021; 9(10): 1345 doi: 10.3390/biomedicines9101345
25
Qun Cai, Mingyan Zhu, Jinnan Duan, Hao Wang, Jingdan Chen, Yixin Xiao, Yangqin Wang, Jianfang Wang, Xuewen Yu, Hui Yang. Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular CarcinomaFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.786873
26
Mohammed Abdul-Latif, Katherine Townsend, Charles Dearman, Kai-Keen Shiu, Khurum Khan. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectivesCancer Treatment Reviews 2020; 88: 102030 doi: 10.1016/j.ctrv.2020.102030
27
Shvetank Bhatt, Jovita Kanoujia, Arghya K. Dhar, Rakesh K. Singh, Jayaraman Rajangam. Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular CarcinomaCurrent Cancer Therapy Reviews 2021; 17(2): 148 doi: 10.2174/1573394716999200818103724
28
Jihao Cai, Minglei Zhou, Jianxin Xu. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinomaWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02354-8
29
Ningning Liu, Xiaomei Wang, Clifford John Steer, Guisheng Song. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cellsGut 2021; : gutjnl-2021-324170 doi: 10.1136/gutjnl-2021-324170
30
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular CarcinomaDiagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
31
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale, Mayur K Virarkar. Advances and effectiveness of the immunotherapy after liver transplantationWorld Journal of Gastrointestinal Surgery 2022; 14(6): 629-631 doi: 10.4240/wjgs.v14.i6.629
32
Paola De Cicco, Giuseppe Ercolano, Angela Ianaro. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune EvasionFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01680
33
Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Didier Bazan Russo, Gianni Pantuso, Antonio Russo, Viviana Bazan. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?Critical Reviews in Oncology/Hematology 2022; 170: 103597 doi: 10.1016/j.critrevonc.2022.103597
34
Sushrut Kamerkar, Charan Leng, Olga Burenkova, Su Chul Jang, Christine McCoy, Kelvin Zhang, Kevin Dooley, Samuel Kasera, Tong Zi, Sílvia Sisó, William Dahlberg, Chang Ling Sia, Shil Patel, Karl Schmidt, Kyriakos Economides, Timothy Soos, Dalia Burzyn, Sriram Sathyanarayanan. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activityScience Advances 2022; 8(7) doi: 10.1126/sciadv.abj7002
35
Aswathy R. Devan, Ayana R. Kumar, Bhagyalakshmi Nair, Nikhil Ponnoor Anto, Amitha Muraleedharan, Bijo Mathew, Hoon Kim, Lekshmi R. Nath. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular CarcinomaPharmaceuticals 2021; 14(7): 656 doi: 10.3390/ph14070656
36
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
37
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. The current landscape of single-cell transcriptomics for cancer immunotherapyJournal of Experimental Medicine 2021; 218(1) doi: 10.1084/jem.20201574
38
Bingfeng Zuo, Yang Zhang, Kangjie Zhao, Li Wu, Han Qi, Rong Yang, Xianjun Gao, Mengyuan Geng, Yingjie Wu, Renwei Jing, Qibing Zhou, Yiqi Seow, HaiFang Yin. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responsesJournal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01266-8
39
Ming-Cheng Guan, Ming-Da Wang, Si-Yu Liu, Wei Ouyang, Lei Liang, Timothy M Pawlik, Qiu-Ran Xu, Dong-Sheng Huang, Feng Shen, Hong Zhu, Tian Yang. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedsideWorld Journal of Gastrointestinal Oncology 2021; 13(4): 197-215 doi: 10.4251/wjgo.v13.i4.197
40
Sidra Zafar, Baogang Bai, Jinlei Guo, Syed Aun Muhammad, Syeda Tahira Qousain Naqvi, Muhammad Nauman Shabbir, Imran Imran, Rehan Sadiq Shaikh, Amjad Ali, Bing Niu. Experimental Study of Potential CD8+ Trivalent Synthetic Peptides for Liver Cancer Vaccine Development Using Sprague Dawley Rat ModelsBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4792374
41
Fei Kong, Meishan Jin, Donghui Cao, Zhifang Jia, Yawen Liu, Jing Jiang. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinomaPeerJ 2020; 8: e9949 doi: 10.7717/peerj.9949
42
Yi Wang, Na Li, Di Tian, Chang-Wu Zhou, You-Hua Wang, Chun Yang, Meng-Su Zeng. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular CarcinomaCancer Management and Research 2021; : 6451 doi: 10.2147/CMAR.S322179
43
Zhen Lin, Yi-Zhao Xie, Ming-Chun Zhao, Pin-Pin Hou, Juan Tang, Guang-Liang Chen. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinomaCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02173-7
44
Xiaopu Sang, Fenfang Wu, Di Wu, Shan Lin, Jingyi Li, Nan Zhao, Xiaoni Chen, Anlong Xu. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular CarcinomaFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00112
45
Davide De Battista, Fausto Zamboni, Hannah Gerstein, Shinya Sato, Tovah E Markowitz, Justin Lack, Ronald E Engle, Patrizia Farci. Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCCJournal of Hepatocellular Carcinoma 2021; : 1399 doi: 10.2147/JHC.S325959
46
Kai Dai, Yin Wu, Sha She, Qian Zhang. Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2021; 13(12): 2029-2037 doi: 10.4251/wjgo.v13.i12.2029
47
Liang Sun, Shian Yu, Cairong Dong, Zhengyi Wu, He Huang, Zhendong Chen, Zhipeng Wu, Xiangbao Yin. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular CarcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.913398
48
Cheng-Maw Ho, Rey-Heng Hu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee. Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further InvestigationClinical Medicine Insights: Oncology 2020; 14: 117955492096877 doi: 10.1177/1179554920968774
49
Lucile Dumolard, Julien Ghelfi, Gael Roth, Thomas Decaens, Zuzana Macek Jilkova. Percutaneous Ablation-Induced Immunomodulation in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2020; 21(12): 4398 doi: 10.3390/ijms21124398
50
宇 郭. Progress in the Treatment of Hepatocellular Carcinoma Based on Hepatic Arterial Infusion ChemotherapyAdvances in Clinical Medicine 2022; 12(01): 587 doi: 10.12677/ACM.2022.121087
51
Sandra Mirie Kang, Lana Khalil, Bassel F. El-Rayes, Mehmet Akce. Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-OncologyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.821903
52
Guobo Xie, Yinting Zhu, Zhiyi Lin, Yuping Sun, Guosheng Gu, Weiming Wang, Hui Chen. HOPMCLDA: predicting lncRNA–disease associations based on high-order proximity and matrix completionMolecular Omics 2021; 17(5): 760 doi: 10.1039/D1MO00138H
53
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
54
Wen Yin, Xingjun Jiang, Jun Tan, Zhaoqi Xin, Quanwei Zhou, Chaohong Zhan, Xianyong Fu, Zhaoping Wu, Youwei Guo, Zhipeng Jiang, Caiping Ren, Guihua Tang. Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade GliomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01409
55
Bryan Mckiver, Mohamad Imad Damaj, Devanand Sarkar. Assessment of Current Gene Therapy Practices in Hepatocellular CarcinomaGastrointestinal Disorders 2020; 2(4): 469 doi: 10.3390/gidisord2040042
56
Wentao Jia, Lina Wang. Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor ImmunityEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9843486
57
Yi Hu, Dan Chen, Minjing Hong, Jing Liu, Yijia Li, Jianlei Hao, Ligong Lu, Zhinan Yin, Yangzhe Wu. Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell ImbalanceFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.845974
58
Linfeng Xu, Xingxing Jian, Zhenhao Liu, Jingjing Zhao, Siwen Zhang, Yong Lin, Lu Xie. Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular CarcinomaFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.741226
59
Kexin Li, Ashley Zhang, Xiaoya Li, Hongtao Zhang, Lianmei Zhao. Advances in clinical immunotherapy for gastric cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188615 doi: 10.1016/j.bbcan.2021.188615
60
Adam Swersky, Laura Kulik, Aparna Kalyan, Karen Grace, Juan Carlos Caicedo, Robert J. Lewandowski, Riad Salem. Contemporary Algorithm for the Management of Hepatocellular Carcinoma in 2021: The Northwestern ApproachSeminars in Interventional Radiology 2021; 38(04): 432 doi: 10.1055/s-0041-1735528
61
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinomaSaudi Journal of Gastroenterology 2020; 26(7): 1 doi: 10.4103/sjg.SJG_477_20
62
Lin Yu, Nan Huang, Heng Sun, Xi Yang, Yuna Fu, Qiaoli Lang, Jianhua Wang, Liangpeng Ge. Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular CarcinomaJournal of Immunotherapy 2021; 44(3): 106 doi: 10.1097/CJI.0000000000000349
63
Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo, Xing Lai, Fu Wang. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular CarcinomaJournal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/6535009
64
Thomas De Somer, Erik Vanderstraeten, Vincent Bouderez, Els Monsaert, Christophe Van Steenkiste. Resolution of a hepatoduodenal fistula after nivolumab treatment in a patient with hepatocellular carcinoma: challenges in immunotherapyActa Clinica Belgica 2022; 77(1): 108 doi: 10.1080/17843286.2020.1778346
65
Shao-Ru Liu, Qing Yan, Hao-Ming Lin, Guang-Zi Shi, Yi Cao, Hong Zeng, Chao Liu, Rui Zhang. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reportsWorld Journal of Clinical Cases 2021; 9(21): 5988-5998 doi: 10.12998/wjcc.v9.i21.5988
66
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
67
Yanlin Du, Da Zhang, Yiru Wang, Ming Wu, Cuilin Zhang, Youshi Zheng, Aixian Zheng, Xiaolong Liu. A highly stable multifunctional aptamer for enhancing antitumor immunity against hepatocellular carcinoma by blocking dual immune checkpointsBiomaterials Science 2021; 9(11): 4159 doi: 10.1039/D0BM02210A
68
Andreas Koulouris, Christos Tsagkaris, Michail Nikolaou. Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last YearsToxins 2021; 13(2): 149 doi: 10.3390/toxins13020149
69
Rohini Sharma, Leila Motedayen Aval. Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular CarcinomaFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.652007
70
Wanbang Zhou, Yiyang Chen, Ruixing Luo, Zifan Li, Guanwei Jiang, Xi Ou. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression NetworkPathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.601693
71
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary CancersTrends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
72
Chunchen Wu, She Tian, Yuting Guo, Chao Yu, Linhan Lei, Dijie Zheng, Huahua Xie, Jian Zheng, Chengyi Sun, Fu Wang. circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR PathwayJournal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/8649386
73
Debashri Manna, Devanand Sarkar. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular CarcinomaCancers 2020; 12(5): 1243 doi: 10.3390/cancers12051243
74
Sanghwa Kim, Minji Lee, Yeonhwa Song, Su-Yeon Lee, Inhee Choi, I-Seul Park, Jiho Kim, Jin-sun Kim, Kang mo Kim, Haeng Ran Seo. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01912-y
75
Vikrant Rai, Sandeep Mukherjee. Targets of immunotherapy for hepatocellular carcinoma: An updateWorld Journal of Hepatology 2022; 14(1): 140-157 doi: 10.4254/wjh.v14.i1.140
76
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational ModelingCancers 2021; 13(21): 5583 doi: 10.3390/cancers13215583
77
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future PerspectivesInternational Journal of Molecular Sciences 2022; 23(12): 6664 doi: 10.3390/ijms23126664
78
Hung-Wei Cheng, Yu-Ling Ou, Chia-Chi Kuo, Hsin-Yi Tsao, Huai-En Lu. Ansamitocin P3-Loaded Gold-NanoCage Conjugated with Immune Checkpoint Inhibitor to Enhance Photo-Chemo-Thermal Maturation of Dendritic Cells for Hepatocellular CarcinomaPolymers 2021; 13(16): 2726 doi: 10.3390/polym13162726
79
Wei Wang, Bo Sun, Yang Xia, Shenghong Sun, Chiyi He. RNA N6-Methyladenosine-Related Gene Contribute to Clinical Prognostic Impact on Patients With Liver CancerFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00306
80
Rui Wang, Hui Guo, Xiaotong Tang, Tiantian Zhang, Yang Liu, Cheng Zhang, Hanbing Yu, Yumei Li. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma CellsInflammation 2022; 45(1): 308 doi: 10.1007/s10753-021-01547-3
81
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro, Fabrício Freire de Melo. Oncolytic virus therapy in cancer: A current reviewWorld Journal of Virology 2021; 10(5): 229-255 doi: 10.5501/wjv.v10.i5.229
82
Neehar D Parikh, Alexander Marshall, Keith A Betts, Jinlin Song, Jing Zhao, Muhan Yuan, Aozhou Wu, Keith D Huff, Richard Kim. Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinomaJournal of Comparative Effectiveness Research 2021; 10(5): 343 doi: 10.2217/cer-2020-0236
83
Ningning Liu, Clifford J. Steer, Guisheng Song. MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc miceHepatology 2022; 76(1): 32 doi: 10.1002/hep.32182
84
Zhou Lu, Ronghua Liu, Yining Wang, Mengxia Jiao, Zhongchen Li, Zhiqiang Wang, Cheng Huang, Guoming Shi, Aiwu Ke, Luman Wang, Ying Fu, Jie Xia, Haoyu Wen, Jian Zhou, Xiaoying Wang, Dan Ye, Jia Fan, Yiwei Chu, Jiabin Cai. Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinomaHepatology 2022;  doi: 10.1002/hep.32442
85
Shun Zhou, Jian Xu, Dong Wang, Yong Wang, Lijuan Meng, Song Cao. Development an Immune-Related MicroRNA Risk Index in Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5224434
86
Siyuan Song, Peng Shu. Expression of ferroptosis-related gene correlates with immune microenvironment and predicts prognosis in gastric cancerScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12800-6
87
Indranil Banerjee, Paul B. Fisher, Devanand Sarkar. Advances in Cancer Research 2021; 152: 329 doi: 10.1016/bs.acr.2021.05.003
88
Yue Chen, Haoyue Hu, Xianglei Yuan, Xue Fan, Chengda Zhang. Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular CarcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.896752